Clinical Trials in Baltimore

Showing 22001-22020 of 23,476 trials

Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis

NCT00085644

The objective of this study was to evaluate the safety and efficacy of adalimumab 40 mg given every other week (eow) in subjects with active ankylosing spondylitis (AS) who have had an inadequate response to, or who are intolerant to, treatment with at least 1 nonsteroidal anti-inflammatory drug (NSAID) and who may have also failed treatment with at least 1 disease-modifying antirheumatic drug (DMARD).

Ankylosing Spondylitis

Abbott315 participantsStarted Jan 2004

Birmingham, Alabama, United States • Mobile, Alabama, United States • San Francisco, California, United States +19 more locations

COMPLETEDPhase 3< 1 mile

An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

NCT00696436

The purpose of this study is to evaluate the efficacy and safety of azilsartan medoxomil, once daily (QD), compared to placebo, valsartan and olmesartan in participants with essential hypertension.

Hypertension

Takeda1,291 participantsStarted Apr 2008

Alabaster, Alabama, United States • Ozark, Alabama, United States • Green Valley, Arizona, United States +128 more locations

Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis

An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

Find Trials by Condition in Baltimore

Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail

Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy

Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder

A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs

DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Comparison of Three Methods of Taking Temperatures in the Well Baby Nursery

Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)

Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy

International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa

A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To

One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria

A 2 Week Blinded Study For Pain Due To Arthritis Of The Knee

Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder

Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair

Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty